RecruitingNCT06421805

Establishing Prospective Mediastinal Tumor Database of PUMCH

A Single-center, Prospective, and Observational Study on Population Characteristics, Pathological Features, and Prognostic Factors of Patients With Mediastinal Tumor: Establishing Mediastinal Tumor Database of PUMCH.

Sponsor

Peking Union Medical College Hospital

Enrollment

2,000 participants

Start Date

Jan 1, 2012

Study Type

OBSERVATIONAL

Conditions

Germ Cell Tumor Lymphoma Thymic Epithelial Tumor Teratoma Thymic Cyst Retrosternal Goitre Schwannoma

Summary

This study aims to prospectively document the population characteristics, imaging findings, pathological features, prognostic factors, etc., of patients with mediastinal tumors. Clinical information will be structured and processed, and it is recommended to establish a mediastinal tumors database at Peking Union Medical College Hospital. The goal is to provide support for the quality of diagnosis and treatment, clinical protocols, and medical decision-making related to mediastinal tumors.

Eligibility

Plain Language Summary

Simplified for easier understanding

This study is building a medical database of patients with tumors in the mediastinum (the space in the chest between the lungs). By collecting detailed clinical, imaging, and pathology information, researchers aim to better understand these rare tumors and improve diagnosis and treatment. **You may be eligible if...** - You have been clinically or pathologically diagnosed with a mediastinal tumor - You are able to provide written consent **You may NOT be eligible if...** - Your medical records are incomplete (missing clinical or pathological information) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

Peking Union Medical College Hospital

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06421805

Related Trials

Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy

NCT052379863 locations

Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid in Combination With Polatuzumab (ViPOR-P) in Relapsed/Refractory B-cell Lymphoma

NCT047398131 location

PT-112 in Subjects With Thymoma and Thymic Carcinoma

NCT051047361 location

Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas

NCT032585671 location

A Study of Pembrolizumab in Japanese Pediatric Participants With Solid Tumors or Lymphomas and Japanese Adult Participants With Merkel Cell Carcinoma (MK-3475-G21/KEYNOTE-G21)

NCT073023473 locations